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and a New Approach to the Intravenous Glucose Tolerance Test
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(Eingegangen am 25. März 1966)
The analysis of 197 glucograms is presented and the authors discuss some new points of clinical importance in the
appraisal of the diabetic state. The suggestion is also made that when the sulphonylurea test is done, it should
follow sequentially an intravenous glucose tolerance test. Further, it was found that in assessing the result of an
intravenous glucose tolerance test it is of importance to take into account the blood sampling method, and whether
the patient is ambulant or confined to bed. A simplified intravenous glucose tolerance test is suggested which
requires 3 blood samples only, takes less than an hour to perform and derives the K-value from a simple table. The
Correlation of the various tests and their clinical interpretation is discussed.
Die Arbeit beschäftigt sich mit der Analyse von 197 Glucogrammen. Anhand dieses Materials werden einige neue
Gesichtspunkte für die Diabetes-Diagnose diskutiert. Unter anderem wird vorgeschlagen, daß der Sulfonylharnstoff-
Test immer anschließend an einen intravenösen Glucosebelastungstest gemacht wird, und, daß bei der Beurteilung
cies intravenösen Glucosebelastungstests sowohl die Art der Blutprobe, als auch der Unterschied zwischen ambu-
lanter oder stationärer Untersuchung berücksichtigt werden muß. Eine vereinfachte Methode dieses Tests, die nur
drei Blutproben verlangt und in einer Stunde beendigt ist, und in der man den K-Wert von einer Tabelle abliest, ist
erstmalig beschrieben. Die Beziehung der verschiedenen Tests zueinander und ihre klinische Interpretation wird
ausführlich besprochen.
The glucogram is a continuous recording of a person's
blood glucose level. This can be achieved simply by
connecting an intravenous catheter resting in the ante-
cubital vein with an AutoAnalyzer which has been set to
analyze glucose by the glucose-oxidase-peroxidase re-
action. Details of this procedure have been described by
KAWERAU (1) in a previous publication.
Very little use has so far been made of the continuous
intravenous sampling technique, and this is surprising,
since it was developed in the United States of America,
the home of the AutoAnalyzer. Continuous monitoring
of the blood glucose level was begun by WELLER et al.
.(2) for observing the pharmacological effect of the oral
hypoglycaemic biguanide Phenformin and by FERRARI
et al. (3) for perfusion experiments of various organs of
the rabbit. More recently, BURNS and BREGNANT (4)
published glucograms of the oral glucose tolerance test
("OGTT") which resemble our own, which we present-
ed to the Vth International Congress of Clinical Chemistry in
Detroit in 1963; however, these glucograms do not
reveal much of clinical interest. In latter years, the
continuous technique has been largely developed in
France by a team around GALLI, and their glucose work
dates from 1961 (5), These French workers have been
very active in developing continuous monitoring techni-
ques and their most recent work extends to blood
ammonia (6). Glucograms following the intravenous
administration of glucose were observed by these
French workers to show features which cannot be
revealed by the discontinuous technique and it is for this
reason that most of our work has been devoted to the
continouously recorded intravenous glucose tolerance
test
Now at St. Mary's Hospital, Eastbourne, Sussex, England.
Material and Methods
Normal controls
Healthy young adults were asked especially to take part in the test,
and this group we refer to as "Volunteer Controls"; the other
"Controls" were hospital patients who had no endocrine ab-
normality and these we refer to as "Hospital Normals". All the
usual tests fot the diagnosis of diabetes were normal in these
patients. All patients showing some disorder of carbohydrate
metabolism, or whose clinical or familial background showed a
predisposition to diabetes were classified by the system advocated
by the British Diabetic Association (7).
Site of sampling
For all tests the same type of disposable pre-sterilized catheter
("Bardic Intracath" Nor. 17,8" long) was used. To avoid pain it
was always introduced into a large antecubital vein with the aid of
a small amount of local anaesthetic. Of the 8" length about 5"
remains in the vein so that sampling is probably from the brachial
vein. Most of the patients were given 10 000 Units Heparin i. v.,
which is sufficient to prevent clotting for A—5 hours. When there
were contraindications to the use of systemic heparin then an
external heparinising circuit was used (see (1)), in which case a
shorter length of catheter was used.
Glucose
20—25 m/ of a 50% solution of glucose was injected into an
antecubital vein on the other arm through a No. 1 needle, this
takes usually 2—3 minutes. With continuous recording the
timing of this operation is not critical since the record will show
exactly when and for how long the injection was given.
Sulphonylurea
Tolbutamide, and sometimes chlorpropamide were given. These
were supplied in readily injectable form, either 10 or 20 m/
ampoules. Of tolbutamide 1.0 g was given, of chlorpropamide
0.5 g, but the injectable form of the latter drug is only available by
special request from the manufacturers. No adverse effects were
seen as a result of these injections.
Glucose analysis
Most of our glucograms were recorded with the use of the
HOFFMAN ferricyanide reaction (8) and our manifold has been
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described (9). Latterly we have redesigned the manifold for use
with the glucose-oxidase-peroxidase reaction using the WINCEY
and MARKS reagents (1). Satisfactory records can be obtained with
either reaction but the true glucose reaction is preferable for
diabetic work.
Results
The present work reports on 197 glucograms performed
on 126 patients. A summary of the number of tests is
given in Table 1.
Tab. 1
Work Analysis
Number of Glucograms after
intravenous glucose 98
oral glucose 30
intravenous chlorpropamide 38
intravenous tolbutamide 24
insulin 3
leucine 2
ethanol 2
Total 197
The oral glucose tolerance test
We have come to the conclusion that continuous mon-
itoring of the blood glucose level in this test has no
advantages over the discontinuous traditional procedure.
Figures 1—3 show glucograms of such tests, but apart
from small subsidiary peaks that follow the main ab-
sorption period, little of additional interest can be
derived from these graphic presentations.
Occasionally, it may be useful to do a glucogram in a case
of dumping syndrome to obtain clear evidence of rapid
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Glucogram after 50 g. oral glucose in a volunteer normal subject
180 150 120 90 60 30 0 Standards
Minutes
Fig. 2
Glucogram after 50 g. oral glucose in a diabetic patient
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Record of a test meal in a diabetic patient (the total calorific value
was equal to 50 g. glucose); note absence of hyperglycaemia
absorption and reactive hypoglycaemia. The test must be
performed with the patient in the sitting or standing
position. This was clearly demonstrated in one of our
patients who failed to show any signs of glucose ab-
sorption for 30 minutes, when after being sat up straight,
his blood glucose level rose abruptly. More than half of
the requests for this investigation came to us from the
gastric surgery unit, and we think the method has its use
in these patients. For the straightforward diabetic sus-
pect, however, a glucogram is not indicated as the less
troublesome discontinuous technique adequately copes
with the situation. Our glucograms on this type of
patient have merely gone to show that what we already
know of this test is correct, i. e. the peak absorption
period normally covers the 30—60 minute period after
the oral intake of glucose, whereas in the diabetic
fluctuations are more frequent and the main peak may be
deferred beyond the 60 or even 90 minutes post-
absorptive point. We are speaking here as clinical
pathologists, but there is no doubt that continuous
monitoring of oral glucose tolerance tests can be of
considerable value to the experimental physiologist,
pathologist and pharmacologist.
Insulin, leucine and alcohol tests
Changes following the injection of drugs like adrenaline,
insulin, glucagqn and the sulphonylureas which cause
sudden changes in the blood glucose level can profitably
be recorded by a continuous technique. Table 1 does not
altogether represent the true state of affairs with regard
to insulin. In only three cases did we do an isolated in-
sulin test, but on several occasions we tested for insulin
sensitivity in comatose and semi-comatose diabetic
patients. While the patient is on intravenous therapy it is
quite simple to connect him to the AutoAnalyzer, on and
off, and we have used the machine in the ward for 50 hours
and longer for repeated intermittent periods of testing.
If is quite a dramatic demonstration to be able to show
how the patient's insulin sensitivity increases as his ke-
tosis lightens.
Although we have tested for leucine sensitivity we have
not had a positive response. The technique, however, is
eminently suited for investigating the alleged hypo-
glycaemic attack. We have had only one patient in whom
an insulinoma was confirmed at operation and her
fasting blood sugar level was so low that the diagnosis
was never in doubt; but this patient was not sensitive to
leucine.
Alcohol hypoglycaemia is a condition that is quite well
documented in the United States. FIELD et al. (10) were
able to demonstrate this condition in susceptible indivi-
duals by giving 35—50 m/ ethanol as a 10 per cent
solution by mouth after a 40 hour fast. In our two
patients who were chronic alcoholics, 50 m/ ethanol
given orally after a fast of only 14 hours resulted in a
steady fall of the blood sugar reaching levels 10 mg per
cent below the fasting value within 5 hours. The slow but
steady fall does suggest that hypoglycaemia should be
looked for in the chronic alcoholic.
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The intravenous sulphonylurea test
Glucograms are particularly helpful in this test. They
allow one to prejudge the issue and to rescue the patient
with intravenous glucose should the fall become
severely hypoglycaemic, they also allow a correct assess-
ment of the nidar to be made. If this lowest point of the
blood glucose level reached in the test is deemed to be of
diagnostic significance then our curves show that the
blood sugar must be determined at not less than 10
minute intervals. It is true, the nidar does occupy the
30 minute point most frequently, but in at least half of
the normal curves it may be found anywhere between
20 and 60 minutes. A perusal pf the literature on this
test will show that outhors have varied in their practice,
15, 20 und 30 minute intervals having been used. The
60 minute level has often been used to determine re-
sponsiveness to the homeostatic mechanism, but if the
true nidar is not know this assessment cannot really be
made with certainty. Our results of this test are summa-
rized in Table 2. The normal figures calculated for the
nidar are similar to those reported by ZAROWITZ and
Eis (11) for their non-diabetic group, but they are higher
than those reported by CREUTZFELD et al. (12). Some
difference may arise from the person's preparation prior
to the test, i. e. the dietary regimen, the period of pre-
liminary fasting, etc. In our work the test was standard-
ized, it always followed on an intravenous glucose toler-
ance test.
Test procedure
The patient's dietary history is enquired into and when
necessary instructions are given to partake of a liberal
carbohydrate diet prior to the test. Chlorpropamide is
withheld three days before the test, tolbutamide one day
and insulin on the morning of the test. All our tests have
been done with the patient fully undressed and in bed
even when they were Out-patients. They were resting for
at least 30 minutes before they were connected to the
AutoAnalyzer and heparinized and they all received
20—25 g glucose into a vein of the other arm in this
combined test procedure. When it was observed that the
blood glucose level was regaining its fasting level and
a steady state was maintained for some time, at least 10
minutes, then the same arm that had received the glucose
injection now was injected with either 1.0 g tolbutamide
or 0.5 g chlorpropamide intravenously. At this point the
manifold was changed over to the high sensitivity recor-
ding (1, 9). Three typical recordings after chlorpropami-
de are shown in figures 4—6. It is usually unnecessary to
nameiB.Cz.
 mjld diabetic?
age : 31
name: CK.
 h / c poncreof^s
age :BZ *
sensitivity '
, change'
60
Minutes
30 0 Standards
Fig. 5
Ajnoderate diabetic-type of response in~a case'of chronic'pan-
creatitis
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A characteristic normal response to intravenous chlorpropamide
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In this diabetic response the continous recording is particularly
useful as it displays the tendency to delayed hypoglycaemia
continue the recording for more than an hour, as in most
cases it is quite obvious from the shape of the curve what
type of response one is dealing with; should one, how-
ever, wish to obtain information regarding the patient's
liver function, then the test must be continued for at least
two hours (CREUTZFELD et al. (12)). Our own observat-
ions do not extend into this field.
Analysis of the results
A summary of the results is given in Table 2. In the work
of UNGER and MADISON (13) it is suggested that the
percentage fall at 20 minutes is clinically more useful
than the fall at 30 minutes. In our figures we can see no
suggestion that this is so, and as most other workers
have relied on the 30 minute value, we have used this for
the statistical analysis. It is evedint that only the clinically
diabetic group shows a statistically significant fall and
that the tolbutamide test does not differentiate the sub-
groups of diabetes in the British Diabetic Association
Classification. This must be taken to be a provisional
statement as the number of patients in each of these sub-
groups in rather small. It does not mean either that in a
particular case, when all clinical facts are taken together
a sulphonylurea test might not yield important inf orma-
mation. The interpretation of this test is obviously more
complex than the glucose loading tests.
The intravenous glucose tolerance test
Although the intravenous glucose tolerance test has been
known since JACOBSFN (14) introduced it in 1917 and its
clinical interest has been revived in recent years (11, 12,
13, 17), it has not become popular for two main reasons:
it requires an intravenous injection, and in the calculation
of the K-value (the glucose percentage rate of fall per
minute) a formula and a graphic method employing
semi-logarithmic paper have been employed. In other
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Sex
Diabetic
F
F
F
F
M
F
M
F
F
M
M
M
F
M
M
M
F
F
F
Diabetic
F
M
M
F
M
Diabetic
M
M
F
F
M
M
M
Diabetic
M
M
F
M
F
F
M
M
M 'J
Diabetic
M
F
M
M
M
F
F
F
M
Age Drug
Classification:
33
65
79
49
69
25
21
34
41
70
20
47
27
56
23
36
23
75
33
C
C
T
C
C
T
T
C
T
T
T
C
T
T
T
C
T
T
C
Classification:
20
79
20
39
32
C
C
T
T
T
Classification:
17
35
59
49
81
42
48
C
C
C
C
C
T
T
Classification:
49
48
63
73
55
33
50
73
62
T
C
C
C
C
C
C
C
T
Classification:
81
31
68
47
56
75
76
70
85
C
C
T
T
T
C
C
C
C
Tab. 2. Analysis of the Sulphonylurea Test
Response to sulphonylurea
Kg % fall after minutes
(authors) 20 30 40 60
Clinical Notes
Normal
1.47
0.75
1.21
1.14
0.82
0.98
0.55
1.24
1.25
0.99
1.55
0.80
0.99
0.47
0.59
0.84
1.05
1.62
1.52
28
20
31
33
17
5
11
17
25
19
46
15
21
21
44
20
27
20
18
Potential Diabetic
1.06
0.65
0.83
0.96
1.44
Latent
0.98
0.94
1.44
0.57
0.86
2.66
1.01
15
17
49
13
Diabetic (p
4
10
35
13
29
19
15
43
30
45
31
20
16
23
33
33
34
54
19
43
23
39
32
53
45
39
28
37
38
31
24
30
49
8
38
40
24
24
58
29
43
36
64
42
9
14
39
24
20
27
47
33
10
33
32
18
30
50
23
26
8
53
40
13
Normal
Occasional faints
Anterior cardiac infarct
Epileptic on phenobarbitone and epanutin
Tussive syncope
Cerebral atrophy, dementia
Low blood pressure, syncope
Several miscarriages
Overweight, neurodermatitjs
Coronary thrombosis
Normal
Normal, but high alcohol intake
Hiatus hernia repair 1958, vagal crush. Attacks of weak-
ness
Sudden unconsciouness (epileptic)
Cerebral atrophy, dementia apilepsy
Whipple's disease
Premenstrual nocturnal unconsciousness, sweating, head-
ache
Leg ulcers, lapses of consciousness
Amenorrhoea
(p = 0.70)
19
25
28
53
26
= 0.20)
10
22
33
20
31
15
25
33
39
41
30
19
12
27
25
31
15
31
Asymptomatic Diabetes (p ==
0.70
1.04
0.57
0.51
0.72
1.23
0.94
0.80
0.45
20
12
14
15
21
21
11
33
46
24
21
21
30
20
32
20
30
50
30
29
23
35
40
26
45
Clinical Diabetes (p = 0.02 >}
0.53
0.60
0.40
0.29
0.23
0.47
0.20
0.37
0.18
10
22
3
'S
12
6
1
4
13
33
3
14
18
9
2
14
5
9
45
7
24
22
11
14
6
50
26
26
9
13
5
8
33
JLJ
7
36
0.4 <p> 0.5)
55
36
42
26
29
—41
42
48
?> 0.01)
* -s-
21
8
41
30
20
4
23
8
Great-grandmother diabetic; patient has attacks
unconsciousness '
Brother diabetic
of
Brother diabetic; patient had glandular fever and gly-
cosuria; Attacks of weakness
Father diabetic; Overweight
Father diabetic and maternal grandmother; Vaso vagal
syncope
Obese, fainting attacks
Furunculosis and glycosuria, 1960
Gangrene of toe and glycosuria 1940. Normal G. T.
now; last 9 months on chlorpropamide
Occasional glycosuria; Coronary thrombosis
Furunculosis; glycosuria recently
Glycosuria in 1959, not since
T-
Glycosuria in 1953, not since; Attacks of sweating and
weakness
Obese, diabetic oral G. T. T.
Lag oral G. T. T. ; glycosuria
Glycosuria, on steroids, arthritis
Foot ulcer, diabetic oral G. T. T.
On steroids, diabetic oral G. T. T.
Diabetic oral G. T. T., megaloblastic anaemia
Diabetic oral G. T. T., son diabetic
Lag-type G. T. T.; glycosuria
Lag-type G. T. T.; giycosuria
Diabetic for 20 years, on insulin
Diabetic on diet and chlorpropamide for 9 months
Brill-Symmers disease, on insulin
Pancreatectomy for insulinoma in 1954; on serpasil,
glycosuria
Diabetic neuropathy, on chlorthiazide
Recurrent urinary infection
On insulin and chlorpropamide
Admitted in coma, on insulin
Old diabetic on insulin
no
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words, little of the procedure can be handed over to the
technician of the routine laboratory. Our interest in the
method was for two principal reasons; one, theoretical,
to see whether the glucograms yielded some information
related to the pathogenesis of the diabetic state, parti-
cularly the pre-diabetic state; the other, technical, to see
whether the continuously recorded curve would show
some way by which the test could be shortened and
simplified so that it could pass more easily into routine
use.
After the glucose injection, the initial peak is followed by
a rapid fall due to equilibration with the extravascular
space and spill-over into the urine; thereafter follows the
period during which glucose leaves the blood by direct
route to the tissues metabolizing glucose, and none is
added or removed through any other channels. We prefer
to call this phase the "steady state". Later, as the blood
sugar is approaching the fasting level, the homeostatic
mechanism is brought into play and glucose is released
from the liver with a consequent reduction in the rate of
fall. These three phases are clearly shown when the
analytical results are transferred to semi-logarithmic
paper and in many of the glucograms they can also be
seen directly, e. g. figure 7. Experimental work by
FRANCKSON et al. (15) and by SEARLE et al. (16) has
produced convincing evidence that the "steady state" is
maintained during the 15—60 minute period after the
injection of glucose. Analysis of our 98 glucograms has
shown that this period is probably even shorter in the
majority of people and it is on this finding that we have
based our abbreviated intravenous glucose tolerance test
described at the end of this treatise.
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The three phases in the rate of fall of glucose shown directly in a
glucogram
Clinical results
The clinical results are shown graphically in the histo-
gram figure 8. It shows better than statistics that we must
draw the line of normality at a Kg of 0.8; both Volunteer
Controls and Hospital Normals show an abrupt start here.
This may be an artefact because of the relative small
number of cases, but as it has repeated itself in two
different groups, we think it must be of some signi-
ficance. The clear gap betweea the normal and diabetic
group has obviously been brought about by the adoption
of the British Diabetic Association Classification of
Diabetes. Our finding here speaks for the soundness of
this classification. As one would expect, the overlap is
entirely confined to the "potential", "latent" and
"asymptomatic" groups.
Fig. 8
Distribution of the Kg-value in the Normal and Diabetic Groups
In analyzing our Volunteer Controls and Hospital
Normals for age and sex difference of glucose utilization
(see Tab. 3) we find that there is an insufficient number
of males in each of the age groups; all we can say is that
the average Kg value for females is higher than that for a
particular group as a whole. However, if we take all
normal controls together the number are sufficient and
we find a Kg value for males of 1.09 as against 1.27 for
females. The age difference for glucose utilization is well
established (17, 19). We have grouped our patients in the
manner of LUNDBAEK (17) but have failed to notice
an appreciable age difference for our Hospital Normal
group. The small difference noted is not statistically
significant and possibly due to differences in sex distri-
bution for each group. SILVERSTONE et al. in two different
test series using the intravenous glucose tolerance test
(18 and 18 a) reported identical figures for males and
females whereas MOORHOUSE et al. (19) report a difference
of 0.41 for the two sexes. The discrepancy is probably
due to the greater or lesser degree to which the first
15 minute period was excluded from the calculation. We
would conclude from our obersvations that in the hospi-
tal group age difference is not as important a factor as the
sex of the patient.
Figure 8 also explains the difference in the average Kg-
value for the Volunteer Controls as compared with the
Hospital Normals. The difference is due to the presence
of a few individuals with a disproportionately high Kg
value in the Volunteer Control group, but basically the
histogram for the two groups is approximately the same.
STOWERS et al. (20) have pointed out that there is a
difference in glucose utilization for ambulant persons as
compared with the bedridden patient. Only a few of our
Hospital Normals werd bedridden in the narrow sense
of this term. Table 3 certainly points to the necessity for
making this distinction. It is, of course, arguable on what
basis one should assess normality, but as the pathologist is
so often asked to investigate the hospital patient who has
been in bed for some time, he should be aware of this
difference. Conversely, in screening programmes of
normal populations standards must be used which relate
to the particular group unter test.
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Tab. 3. Different Kg-Values
Normal Kg Value for Venous Sampling (Authors)
No. in Group (total)
Mean age
Mean Kg (total)
Mean Kg (females)
Volunter
Controls
Age < 50 years
12
31
1.49
1.57 (N = 8)
Hospital Normals
< 50 years
15
32
1.11
1.14(N=8)
50 — 70 years
11
59
1.05
1.11 (N = 7)
> 70 years
6
79
1.13
1.24 (N = 4)
No. in Group (total)
Mean Kg (men)
Mean Kg (women)
Mean Kg (total)
Nor mal Kg Value for Capillary Sampling (LUNDBAEK)
140
1.67 1.37
1.88 1.74
1.64
1.38
1.29
Normal Kg Values for Venous Sampling (other Authors)
Number of volunteers
33
12
11
12
Age Males Kg
50 (?) 1.45
25—37 1.68
42—58 1.44
65—87 0.98
child-bearing age
Females Kg
1.86
1.68
Authors
MOORHOUSE et al. (1963)
SILVERS-TONE et al. (1957)
SILVERSTONE et al. (1957)
SILVERS-TONE et al. (1957)
SILVERS-TONE et al. (1963)
Kg Value of the Diabetic Groups for Venous Sampling (Authors)
Group
Potential Diabetics
Latent Diabetics
Asymptomatic Diabetic
Clinical Diabetic
Total
Number
6
9
13
23
Mean
Age
45
45
53
64
Mean
Kg
1.02
1.09
0.71
0.41
Tatest
against ' against
Volunteer Hospital
Controls Normals
0.3 < p < 0.4
0.3 < p < 0.4
0.02 < p < 0.05
p < 0.001
0.8 < p < 0.9
0.9 < p
0.01 < p < 0.02
p < 0.001
The difference between our results for "Volunteer Con-
trols" and those of LUNDBAEK for hospital normals, we
think can be explained on the difference of sampling
technique. LAWRENCE pointed out in 1947 (21) that such
differences in technique cannot be ignored: on the other
hand, MARKS and MARRACK (22) state categorically that
there is no difference in the Kg value for venous blood
as compared with capillary blood, and in support they
cite a number of authors. Although the blood sugar level
gives a small and constant arterio-venous difference in
the fasting state, the difference can become quite large
during glucose loading and BUTTERFIELD and ROLLING
(23) have found differences as large as 60 mg/100 m/.
Hence, one would expect the sampling method to be of
paramount importance for the determination of the Kg
value.
In this connection it must be mentioned that we do not
think that our lower Kg values are due to the use of
heparin. On numerous occasions we have first recorded
the fasting blood sugar level and then heparinized the
patient without noticing any difference in the fasting
blood sugar level. On four occasions has it been possible
to repeat a test on the same patient without using
heparin and in each instance there has been no signi-
ficant difference in the Kg value. Two of these experi-
ments are recorded in the repeat tests presented in
Table 4. Our own experience finds support in BUTTER-
FIELD'S work (24) who also has not been able to de-
monstrate any marked difference in the rate of glucose
utilization in heparinized preparations.
The Student "T" test calculation was applied to the
figures of Table 3 and the four .diabetic groups were
Tab. 4. Repeated intravenous Glucose Tolerance Tests
No. Age Sex 1st Test 2nd Test Remarks
42
52
67
28
8
4
34
64
30
25
43
70
82
56
81
50
50
79
M
F
F
M
F
M
M
M
F
Kg = 0.87
Kg =1.11
Kg = 0.49
Kg = 1.02
Kg = 0.99
Kg = 0.56
Kg = 0.70
Kg = 0.94
Kg = 0.47
Kg = 0.99
Kg =1.02
Kg = 0.65
Kg =1,32
Kg = 0.79
Kg = 0.53
Kg = 0.81
Kg =1.25
Kg = 0.47
1st test without heparin, 2nd test with heparin (interval 4 hours)
1st test with heparin, 2nd test without
1st result on venous blood, 2nd capillary blood (same test)
1st venous blood, 2nd capillary blood (same test)
2nd test one year after first (no treatment)
2nd test done some months later with glucose oxidase
2nd test 3 months after dieting
2nd test after one year on chlorpropamide
2nd test one day after 1st
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compared both against the Volunteer Controls and the
Hospital Normals. The only two groups for which the
results were significant was the "asymptomatic diabetic
group" (p 0.01 p. 0.02) and the "clinical diabetic group"
(p. 0.001). Hence this test has a slightly higher discrimi-
natory power than the intravenous tolbutamide test.
Correlation between the intravenous glucose
and the intravenous sulphonylurea test
In order to test this correlation further we arranged 48 of
the combined test results in ascending order of Kg value.
These figures are shown in Table 5. They show that for
Kg values above 0.80 there is.no correlation with the
sulphonylurea test. The slight positve correlation be-
stowed on the group of tests as a whole is largely due to
the diabetic component. We have obtained this result in
spite of the fact that our sulphonylurea test was carried
out under standardised conditions. The implication is
that the sulphonylurea test does not help to distinguish
the various forms of diabetes in the British Diabetic
Association classification, although it may give a perfectly
vali'd result in any particular person. Furthermore, it
signifies that our interpretation of this test has a not
readily grasped component which eludes us at present.
It is quite possible that this component is linked to
"complexed" circulating insulin which becomes released
by sulphonylurea, particularly in the presence of heparin,
as it has recently been shown by GUNDERSEN and LIN (25)
that heparin can "decomplex" insulin. DOLGER et al. (26)
found that the IVTT is no better than the oral GTT in
the detection of diabetes in pregnancy and POTE et al. (27)
also noted the lack of correlation between the cortisone
GTT, oral GTT and intravenous GTT. It thus appears
that each test has its own interpretation and that to look
for a strict correlation between all of them merely displays
our ignorance.
Tab. 5
Correlation between Kg and sulphonylurea test
No.
66
80
51
67
45
18
75
63
93
47
39
29
4
50
79
6
54
48
84
15
r =
Kg
0.20
0.18
0.23
0.37
0.29
0.40
0.47
0.46
0.45
0.57
0.57
0.55
0.56
0.51
0.59
0.75
0.72
0.65
0.70
0.60
+ 0.73
Total
% fall
2
5
19
14
14
3
23
9
30
20
21
23
13
22
39
30
30
25
46
33
No.
71
65
52
27
72
74
58
83
26
81
14
77
69
7
44
41
3
13
2
62
64
91
89
40
38
82
78
85
r = + 0.01
number = 48; r for total = -f
Kg
0.80
0.86
0.86
0.98
0.80
0.99
0.99
0.84
0.82
0.96
0.94
0.83
1.55
1.55
.24
.06
.14
.21
.29
.23
.25
.62
.05
1.44
1.04
1.44
1.11
2.66
0.44
% fall
20
31
32
27
20
43
34
32
18
53
29
29
54
25
33
20
31
45
43
30
32
. 45
53
16
24
27
50
19
A simplified intravenous glucose tolerance, test
All our glucograms after intravenous glucose were analy-
zed by theLuNDBAEK technique (17). Ten minute readings
were taken from the curves and the values transferred to
semi-logarithmic paper, the best fitting line for the first
hour points was drawn (fig. 9) and the time noted tor the
blood sugar to fall to half its value. This time was
inserted into the LUNDBAEK formula (see tab. 6) and the
Kg value calculated therefrom. The following difficulties
were noted: — (1) many times the points lay on a curve,
which meant that the straight line could only be drawn
by ignoring some upper or lower points and one had a
choice of slopes; (2) in diabetics, often extrapolated
figures had to be used in order to arrive at a half glucose
value, this is both cumbersome and causes inaccuracies;
and (3) more than half our lines so drawn have shown
definite angulations between the 10 and 20 minute
points and between the 40 and 60 minute points; this is
illustrated in fig. 10. Such changes in the rate of fall
were seen in both normals and diabetics, but they are
more common in the normal person. We like to think
that these angulation points correspond to the renal and
liver thresholds respectively and that the "steady state"
is only maintained between these points. In other words
a straight line fit cannot be expected between points
lying outside this period. Hence, we decided to restrict
the period of the test to the 30 minutes that can be
expected to lie on this straight line, i. e. the 15—45
minute period after intravenous glucose. In the pre-
paration of this manuscript we came across the inter-
esting paper by WEST and WOOD (28). These authors
anticipated this simplified test, unbeknown to us they had
advocated it in 1959, quote: — ". . . . we conclude that
glucose tolerance could be easily estimated with con-
siderable accuracy by determining the rate of fall of the
blood glucose during a period of approximately 30
minutes at a time when the levels of blood glucose arc a
little below the renal threshold, but above the normal
fasting level. Since the per cent per minute fall is constant
300
350
300
100
50
0,52
Afc 1,96
Ο 10 ΪΟ 30 W 50 60 70
Minutes
Fig. 9
The best fit line for the first seven points of the test on semi-
logarithmic paper.
Note the time for the blood sugar level to fall to half its value
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30 40
Minutes
Fig. 10
Some examples of difficult "best-fits" and angulation points
during this period, it seems likely that (the) glucose
(fall) could be estimated accurately by performing only
two blood glucose determinations." This conclusion
they arrived at after careful personal work with the
intravenous glucose tolerance test and a most searching
enquiry into the results obtained by the other leading
investigators in this field — AMATUZIO, CONARD and
DUNCAN. We were led to the same conclusion from a
careful study of our 98 intravenous glucograms. As far
as we are aware the recommendation of WEST and WOOD
has never been carried into effect.
Calculation of the result
L NDBAEK makes use of the simple formula recommend-
ed by HAMILTON and STEIN, he simplifies it further by
using a predetermined blood sugar value, namely the
half-value. We use basically the same formula and
simplify it by predetermining the time interval, namely
30 minutes. This is shown in Table 6. Furthermore, by
restricting the calculations to the usually encountered
range of blood sugar levels found in this test, i. έ.
50—300 mg per cent glucose all the k' values can be
reduced to manageable proportions by deducting their
value from the k' value of the 300 blood sugar. The
k' values for glucose levels of 50—300 mg per cent are
found in Table 7.
Tab. 6
The LUNDBAEK formula The authors' formula
For the exponential fall:
BISt = BlS0e-*t
it follows —
In BIS! — lnBlS2
but by chosing time by which BIS falls to % *ts value —
InBlSi —mffl.SBlSi)
then the numerator can be written —
B1SX
also written
In
Kg =
USi X 0.5
0.693
tfc
: In 2 =0.693
X 100 (percentage per minute)
k = - lnB!S2
but by chosing t2—tx to equal 30 minutes —
In BIS! In B1S2
~ ~ 3 0 3 0 ~ ~
in calculating each half of this expression separately —
In BIS
k' = —Ξ«— (x 100) (percentage per minute)
Kg=k'(45) — k'(i6)
(Note: the k' values for blood sugars ^— BG— from
50—300 mg/100 m/ are given in Table 7)
The test procedure
The patient is prepared as for the oral glucose tolerance
test. A specimen of blood is taken for the determination
of the fasting blood sugar level; this is usually of interest
to the physician but has nothing directly to do with the
determination of the Kg-value. 25 grams of glucose
(50 m/ of a 50% solution) are then injected into an ante-
cubital vein within a period of 2—3 minutes. By using a
No. 1 needle the speed regulates itself on account of die
high viscocity of the solution. Blood is taken again
15 and 45 minutes after the injection. Urine is not
collected. Taking the fasting blood sample and giving
the injection takes usually 6 minutes, it has been found
possible thus for one worker to deal with 6 patients in a
period of 2 hours giving the injections and taking all the
blood samples himself.
When the laboratory results for the blood sugars are
available, the k' value for the 15 minute and 45 minute
blood sugar are read from Table 7 and deducted from
each other, thus giving the Kg value for the test.
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Tab. 7. Table for the calculation of the 30 minute Kg value
B.C. k' B.O. k' B.G. B.O. k' B.G. k' B.G. k' B.G. k' B.G. k' B.G. B.G. k'
299 0.01
298 0.02
297 0.03
296 0.04
295 0.05
294 0.07
293 0.08
292 0.09
291 0.10
290 0.11
289 ' 0.12
288 0.14
287 0.15
286 0.16
285 0.17
284 0.18
283 0.19
282 0.21
281 0.22
280 0.23
279 0.24
278 0.25
277 0.27
276 0.28
275 0.29
274 0.30
273 0.31
272 0.33
271 0.34
270 0.35
269 0.36
268 0.38
267 0.39
266 0.40
265 0.41
264 0.43
263 0.44
262 0.45
261 0.46
260 0.48
259 0.49
258 0.50
257 0.52
256 0.53
255 0.54
254 0.55
253 0.57
252 0.58
251 0.59
250 0.61
249 0.62
248 0.63
247 0.65
246 0.66
245 0.67
244 0.69
243 0.70
242 0.71
241 0.73
240 0.74
239 0.76
238 0.77
237 0.78
236 0.80
235 0.81
234 0.83
233 0.84
232 0.86
231 0.87
230 0.88
229 0.90
228 0.91
227 0.93
226 0.94
225 0.96
224 0.97
223 0.99
222
221
220
219
218
217
216
215
214
213
212
211
210
209
208
207
206
205
204
203
202
201
.00
.02
.03
.05
.06
.08
.10
.11
.13
.14
.16
.17
.19
.20
.22
.24
.25
.27
.29
.30
.32
.33
200 .35
199
198
197
196
195
194
193
192
191
190
189
188
187
186
185
184
183
182
181
180
179
178
177
176
.37
.39
.40
.42
.44
.45
.47
.49
.51
.52
.54
.56
.58
.59
.61
.63
.65
.67
.68
.70
.72
.74
.76
.78
175 .80
174 .82
173 .83
172 .85
171 .87
170 .89
169 .91
168 .93
167 .95
166 .97
165 .99
164 2.01
163 2.03
162 2.05
161 2.07
160 2.10
159 2.12
158 2.14
157 2.16
156 2.18
155 2.20
154 2.22
153 2.24
152 2.27
151 2.29
150 2.31
149 2.33
148 2.36
147 2.38
146 2.40
145 2.42
144 2.45
143 2.47
142 2.49
141 2.52
140 2.54
139 2.56
138 2.59
137 2.61
137 2.64
135 2.66
134 2.69
133 2.71
132 2.74
131 2.76
130 2.79
129 2.81
128 2.84
127 2.87
126 2.89
125 2.92
124 2.95
123 2.97
122 3.00
121 3.03
120 3.05
119 3.08
118 3.11
117 3.14
116 3.17
115 3.20
114 3.23
113 2.25
112 3.28
111 3.31
110 3.34
109 3.37
108 3.40
107 3.44
106 3.47
105 3.50
104 3.53
103 3.56
102 3.60
101 3.63
100 3.66
99 3.70
98 3.73
97 3.76
96 3.80
95 3.83
94 3.87
93 3.90
92 3.94
91 3.98
90 4.01
89 4.05
88 4.09
87 4.13
86 4.16
85 4.20
84 4.24
83 4.28
82 4.32
81 4.36
80 4.40
79 4.45
78 4.49
77 4.53
76 4.58
75 4.62
74 4.67
73 4.71
72 4.76
71 4.80
70 4.85
69 4.90
68 4.95
67 5.00
66 5.05
65 5.10
64 5.15
63 5.20
62 5.26
61 5.31
60 5.36
59 5.42
58 5.48
57 5.54
56 5.59
55 5.65
54 5.72
53 5.78
52 5.84
51 5.91
50 5.97
Example:
B1S(15) = 172 mg/100 m/ and B1S(45) = 124 mg/100 ra/
k'
 (15) = 1.85 k' (45) = 2.95
Kg =2.95—1.85
= 1.10
Reliability of the test
This is simply deduced from a comparison of the LUND-
BAEK 6—7 point test procedure with the authors' 2 point
procedure on 83 glucograms. The results are shown in
Table 8. It would be hard to better the correlation be-
tween the two procedures. This is not surprising since
Tab. 8.
Correlation between Kg values of LUNDBAEK and Kg values of
authors
No.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
34
36
38
78
81
83
86
89
91
93
Total
Lundbaek
1.65
1.47
0.77
0.25
1.15
0.64
0.49
0.84
0.96
1.87
1.97
0.54
1.03
0*53
0*34
0.11
0.48
0.77
0.40
2.92
0.96
1.15
1.26
0.73
0.86
0.73
0.48
0.44
0.33
0.91
0.31
0.71
1.15
0.92
1.23
1.15
0.76
2.96
0.90
1.23
0.40
Authors
1.65
1.29
0.73
0.26
0.98
0.75
0.49
0.99
0.91
1.80
1.63
0.42
1.21
0.94
0.60
0.25
0.40
0.66
0.77
0.50
2.92
1.14
1.10
1.17
0.82
0.98
1.02
0.55
0.47
0*97
0*31
0.70
1.28
1.04
1.11
0.96
L864
1.05
1.62
0.45
number of cases: 83; coefficient
No. Lundbaek
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
57
58
60
61
62
63
8
66
67
68
69
70
71
72
74
75
77
79
82
85
87
90
92
of
0.64
1.34
1.06
1.15
0.04
1.32
0.36
0.92
0.61
0.71
0.69
0.49
0.53
1.20
0.59
0.70
0.65
0.40
1.00
0.40
1.72
1.11
0.49
0.92
0.90
0.19
0.49
0.44
1.92
0.84
0.82
0.80
1.03
0.57
0.87
0.61
1.45
2.46
0.96
0.81
0.76
correlation r
Authors
0.57
1.44
1.06
0.99
0.06
1.24
0.29
0.90
0.57
0.65
0.73
0.51
0.23
1.02
0.56
0.72
0.51
0.30
0.99
0.40
1.77
1,23
0.47
0.94
0.86
0.20
0.37
0.37
1.55
0.81
0.80
0.80
0.99
0.47
0.83
0.59
1.44
2.66
i.Oi0.82
0.78
= + 0.97.
they are both based on the same mathematical concept,
furthermore, in making the straight-line fit in the LUND-
BAEK graphic method, inconvenient points are ignored
which also helps in approximating the results by the two
methods.
We had at one time thought that one additional inter-
mediate point at 30 minutes could serve both as a check-
point for straightness of the line and a check on the
reliability of the laboratory sugar estimation. However,
critical examination of this concept revealed that it would
involve the operator in quite considerable calculations to
achieve this. Such a mid-point in time does not coincide
with the arithmetic mean blood sugar fall for the two
fractional 15 minute periods since the fall is exponential.
If one wished to use the mean value of two separately
calculated 15 minute Kg values, a table similar to table 6
could be constructed without much difficulty. It is one
thing using an additional point in the test, and it is quite
another thing to introduce a "check-point". Not only
would the validity of such a point have to be established
and its range of accuracy, but it would also have to be
interpreted by taking into consideration the accuracy of
the individual laboratory's method of sugar analysis.
Hence, the test would lose its simplicity. We doubt that
clinical accuracy would be improved by going to sucb a
more elaborate procedure. The determination of the Kg
value is problematical in a few cases as is best shown in
figure 11, fluctuations not infrequently occur during the
60
 u, . 30Minutes
Standards
Fig. 11
A normal record after intravenous glucose showing fluctuations
during the first 45 minutes
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first 45 minutes, and although these are of a minor
character they could seriously upset a "check-point" if it
was defined within too narrow limits and lead to the
rejection of a test which over the half hour period could
produce quite an acceptable result. Clinically speaking
we do not know whether a change of 0.1 in the Kg value
is of significance and the borderline between the normal
and abnormal covers 0.3 units of this value, the intro-
duction of more points in the test procedure and
additional checks seems therefore to be merely of aca-
demic interest at present.
Discussion
The pattern of diabetes in population surveys has been
summarized by a publication of the Office of Health
Economics (29) which has estimated that if screening was
applied to the whole population of England and Wales
60.000 new cases would be detected annually. From this
knowledge stems the interest in recent years for devising
suitable tests for the detection of the early diabetic state,
but there has been considerable lack of correlation be-
tween the various tests; as is apparent in our own work.—
If we make the justifiable assumption that the result of a
carefully carried out test procedure has a meaning then
it follows that failure to align with other tests can only
mean that a strict comparison cannot be made and that
interpretation must differ. To say that a test has no
meaning because it fails to align with another test is not
really a valid argument. Non-alignment requires re-
interpretation.
Interpretation of the oral glucose tolerance test may need
reviewing if the work of TURNER and MC!NTYRE (30)
can be confirmed which suggests that glucose in contact
with the intestinal mucosa in man produces a hormone
capable of exerting a powerful stimulus to the insulin
output of the pancreas. Their work would seem to
confirm the earlier work of ARNOULD et al. (31) on dogs.
Alterations in the jejunal mucosa following gastrectomy
and starvation may alter such a response. On this basis
one would not expect the test to correlate strictly with the
intravenous glucose tolerance test. We have not in-
frequently observed a normal oral glucose tolerance test
result coupled with a borderline value for the intra-
venous glucose tolerance test.
Interpretation of the intravenous glucose tolerance test is beset
by a great controversy between those workers who main-
tain that it measures pre-existing tissue held insulin only
and those who suggest that it measures a beta-cell
response to the circulating glucose load. The former
view is chiefly represented by the work of FRANCKSON
et. al (15) and the latter in the recent work of SAMOLS and -
MARKS (32). To the outside observer it is not quite dear
why these views should be mutually exclusive. It is fairly
common in our observation to find low Kg values
associated with high sulphonylurea responses which
would argue in favour of the view held by FRANCKSON and
his group of workers. It would always depend on what
type of patient these test are performed because the pre-
sence of insulin antagonists would modify the response.
If the latter are present in sufficient amount the tissue
could be starved of insulin in the presence of an adequate
pancreatic output of insulin. Intravenous sulphonylurea
does not only stimulate pancreatic output of insulin, it
also releases insulin from its polymer and from binding
to protein. Our work suggests that the discrepancy
observed between the Kg value and the sulphonylurea
response may be due to "complexed" insulinlike
activity ("ILA"). The following case would illustrate
some of the difficulties:
The patient, an elderly male, 62 years of age, a chronic bronchitic,
was found to have glycosuria. The oral glucose tolerance test
showed blood glucose values ^— fasting: 80 mg/100 m/; 30 minutes
after glucose 210 mg/100 m/ after 1 hour 100 mg/100 m/ with
3% sugar in the urine; at 90 minutes 58 mg/100 m/ blood glucose
with 0.2% sugar in the urine and at 2 and 2% hours a blood sugar
of 53 mg/100 m/ with no sugar in the urine. In the intravenous
glucose tolerance test a Kg of 0.45 was obtained which is well
within the diabetic region, but in the intravenous tolbutamide test
a 30% fall was registered ia the first 30 minutes which increased
to 51% at 50 minutes reaching low blood sugar levels between
40 and 50 mg/100 m/which persisted for a considerable length of
time. Although the overall fall was similar to that observed in a
healthy person, the fluctuations (see fig. 12) speak for a diabetic
disposition (5).
nome:C.P.
70 60 50 W 30 30 10
Minutes
Standards..
Fig. 12
Fluctuations in the blood sugar level during an intravenous
tolbutamide test (read from right to left; glucose oxidase method)
The early part of the response to the oral test, which like the
intravenous test relies on the tissue-held insulin gave a diabetic
response, the latter part, i. e. after the jejunal hormone transmitted
stimulus has come into, play, shows, like the tolbutamide test an
almost hypoglycaemic response. This seems a likely interpretation
of such a combination of results.
With more knowledge of the mechanism of our tests for
diabetes we may need to do all three tests discussed above
on every patient, as they may give us some guidance not
only to diagnosis but also to prognosis.
We are grateful to Mr. S. KAWERAU for suggesting and compiling
the simplified Table of k' values and to Dr. G. FRANGLEN for the
statistical analysis. We are also grateful to our colleagues at
St. James' Hospital for access to their patients and to the Photo-
graphic Department for the reproductions. The Technicon Co.,
Chertsey, Surrey we thank for the generous loan of equipment
and Chas. Pfizer, Ltd. for a gift of injectable chlorpropamide and
reprints from their Medical Information Department.
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Indirekte Bestimmung des Kohlenmonoxyds im Blut
Von G. CIUHANDU, V. Rusu, M. DIACONOVTCI und L. Kiss
Aus dem Laboratorium für Toxikologe des Institutes für Hygiene und Arbeitsschutz^ Timisoara> Rumänien
(Direktor: Dr. E. Andriescu)
(Eingegangen am 14. Mai 1965)
Eine früher ausgearbeitete Methode zur Bestimmung des ausgeatmeten Kohlenmonoxyds wurde verbessert.
Bei 80 Personen, die beruflich dem Kohlenmonoxyd exponiert waren, wurde gleichzeitig die Konzentration des
Gases im Blute sowie das in 5 Mini bei Rückatmung von Sauerstoff ausgeschiedene Gas bestimmt. Die graphische
Darstellung der erhaltenen Werte ergibt eine langsam steigende Kurve, die mit einer mittleren Genauigkeit von
±0,5 m/ CO-proz. eine indirekte Bestimmung des'COHb ermöglicht.
Bei einer 5 Min. wahrenden Rückatmung werden etwa 2% des gesamten, im Kreislauf befindlichen Kohlenmonoxyds
ausgeschieden. Unter den beschriebenen Bedingungen wird ein Grenzwert von 2 m/ausgeatmeten Kohlenmonoxyds
als annehmbar vorgeschlagen.
Earlier methods for the determination of expired carbon monoxide have been improved.
In 80 persons, who are exposed to CO in their occupations, the concentration of the gas was measured simultaneously
in the blood and in the expired gas, following the reinspiration of oxygen. The resulting values show, graphically,
a gradually increasing slope, form which the COHb level can be evaluated directly with a maximal dispersion of
db0.5m/CO%.
During 5 min. reexpiration the sample contains about 2% of the total CO present in the circulation. Under the
described conditions, a limit of 2 m/ of expired CO is suggested.
Die Kenntnis des Gehaltes des Blutes an Kohlenmonoxyd
in jedem beliebigen Moment einer gegebenen Zeit?
periode — z. B. während der achtstündigen Arbeits-
zeit -— ermöglicht die korrekte Deutung der unspezi-
fischen Symptome, die bei Personen auftreten, die in
einer CO-haltigen Atmosphäre arbeiten. Die bekannten,
bei der Entnahme von signifikanten Blutproben auf-
tretenden Schwierigkeiten ließen in letzter Zeit das
Interesse an der Untersuchung des ausgeatmeten Gases
wachsen. So schlug 1947 SHEPHERD (1) vor, die Analyse
der ausgeatmeten Luft mit Hilfe eines Molybdat-
Palladiumsalz-Indikatorröhrchens durchzuführen. Ein
Jahr später versuchte SJÖSTRAND (2) den CO-Hb-
Spiegel indirekt dadurch zu bestimmen, daß er die
CO- und O2-Konzentration in dem ausgeatmeten Gas-
gemisch nach Rückatmung von reinem Sauerstoff
analysierte. — JONES und Mitarbeiter (3) gingen im
Jahre 1958 den gleichen Weg und untersuchten das
exhalierte Gas nach dem Einatmen von reinem Sauer-
stoff und darauffolgendem 20 Sek. langem Anhalten
des Atems. Beide Verfahren wurden später in ver-
schiedenen Modifikationen zur Erforschung des Kohlen-
monoxyd-Sättigungszustandes des Organismus ver-
wendet (4—7).
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